LARCHMONT, NY
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)THE BARTH SYNDROME FOUNDATION, founded in 2000, is a community nonprofit in the Philanthropy & Grantmaking sector that reported $1.9M in total revenue in fiscal year 2024. Revenue surged 45% from the prior year, signaling strong growth momentum. Net assets of $5.2M represent 32 months of operating reserves.
THE BARTH SYNDROME FOUNDATION IS AN ENGAGED, GLOBAL COMMUNITY WHOSE MISSION IS SAVING LIVES THROUGH EDUCATION, ADVANCES IN TREATMENTS, AND FINDING A CURE FOR BARTH SYNDROME.
THE BARTH SYNDROME SCIENCE, MEDICINE & RESEARCH PROGRAM IN 2024 WAS COMPRISED OF A) THE BSF RESEARCH PROGRAM TO FOSTER SCIENTIFIC AND CLINICAL INVESTIGATIONS INTO BARTH SYNDROME TO FACILITATE THE...
THE BARTH SYNDROME SCIENCE, MEDICINE & RESEARCH PROGRAM IN 2024 WAS COMPRISED OF A) THE BSF RESEARCH PROGRAM TO FOSTER SCIENTIFIC AND CLINICAL INVESTIGATIONS INTO BARTH SYNDROME TO FACILITATE THE DEVELOPMENT OF A SPECIFIC TREATMENT OR A CURE FOR THIS DISEASE, AND B)THE BARTH SYNDROME MEDICAL DATABASE AND BIO-REPOSITORY FOR THE COLLECTION AND STORAGE OF MEDICAL INFORMATION/SAMPLES ON INDIVIDUALS WITH BARTH SYNDROME OVER TIME TO GAIN A BETTER UNDERSTANDING OF THE DISEASE.
THIS CONFERENCE WHICH IS HELD EVERY TWO YEARS, BRINGS AFFECTED FAMILIES, RESEARCH SCIENTISTS AND CLINICIANS TOGETHER IN ONE PLACE AT A TIME, SO THAT THEY MAY COLLABORATE AND SHARE THEIR KNOWLEDGE TO...
THIS CONFERENCE WHICH IS HELD EVERY TWO YEARS, BRINGS AFFECTED FAMILIES, RESEARCH SCIENTISTS AND CLINICIANS TOGETHER IN ONE PLACE AT A TIME, SO THAT THEY MAY COLLABORATE AND SHARE THEIR KNOWLEDGE TO GAIN A GREATER UNDERSTANDING OF BARTH SYNDROME AND LEARN ABOUT THE LATEST DISCOVERIES AND SCIENTIFIC RESEARCH AVAILABLE. FAMILIES HAVE A UNIQUE OPPORTUNITY TO BE SEEN BY THE WORLD'S GREATEST EXPERTS, THEREBY, CONTRIBUTING DIRECTLY TO THE SEARCH FOR A CURE BY PRODIVING INFORMATION AND TISSUE SAMPLES.
BSF BUILDS AWARENESS OF BARTH SYNDROME TO IMPROVE DIAGNOSIS AND CARE, WHILE ADVANCING ADVOCACY EFFORTS THAT AMPLIFY PATIENT VOICES, MOBILIZE OUR PATIENT COMMUNITY, AND SUPPORT PROGRESS IN RESEARCH...
BSF BUILDS AWARENESS OF BARTH SYNDROME TO IMPROVE DIAGNOSIS AND CARE, WHILE ADVANCING ADVOCACY EFFORTS THAT AMPLIFY PATIENT VOICES, MOBILIZE OUR PATIENT COMMUNITY, AND SUPPORT PROGRESS IN RESEARCH AND TREATMENT ACCESS AND DRUG DEVELOPMENT POLICY
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $1,940,887 | $1,334,806 | +0.5% |
| Expenses | $2,093,891 | $1,421,717 | +0.5% |
| Net Income | $-153,004 | $-86,911 | +0.8% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| BRUCE DEVELLE | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| JONATHAN STOKES | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| MEGAN BRANAGH | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| MICHELLE FLOREZ | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| NINA RUSSELL | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| PETER VAN LOO | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| MIRIAM GREENBERG | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| ANDREW BUDDEMEYER TERM 24 | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| FLORENCE MANNES TERM 24 | BOARD MEMBER | 2.00 |
Director
|
$0 | $0 | $0 |
| KATHERINE MCCURDY | CHAIR | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| JAMES BAFFA | VICE CHAIR | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| MARK GREENE | TREASURER | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| BRANDI DAGUE | SECRETARY | 2.00 |
Officer
Director
|
$0 | $0 | $0 |
| EMILY MILLIGAN | EXECUTIVE DIRECTOR | 35.00 |
Officer
|
$227,314 | $20,819 | $248,133 |
| LINDSAY MARJORAM | DIRECTOR OF RESEARCH | 35.00 |
Highest
|
$174,980 | $7,216 | $182,196 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | No data | No data | No data | No data |
| 2024 | $1,940,887 | $2,093,891 | $5,640,640 | $-153,004 |
| 2023 | $1,334,806 | $1,421,717 | $5,491,330 | $-86,911 |
| 2022 | $1,387,712 | $1,367,327 | $5,372,000 | $20,385 |
| 2021 | $1,563,641 | $1,010,732 | $5,986,941 | $552,909 |
| 2020 | $1,267,165 | $1,001,933 | $5,553,199 | $265,232 |
| 2019 | $1,135,762 | $1,301,376 | $4,993,243 | $-165,614 |
| 2018 | $2,291,095 | $1,155,310 | $4,750,350 | $1,135,785 |
Compare THE BARTH SYNDROME FOUNDATION with other nonprofits in New York and across the country.